{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:22:55Z","timestamp":1791840175481,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Swiss Cancer League","award":["CCRP OCS-01812-12-2005"],"award-info":[{"award-number":["CCRP OCS-01812-12-2005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10456-016-9508-7","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T09:42:55Z","timestamp":1459503775000},"page":"339-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue"],"prefix":"10.1007","volume":"19","author":[{"given":"Ernesta","family":"Fagiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lorentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Bill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirusigan","family":"Pavotbawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Kopfstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Christofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"issue":"7070","key":"9508_CR1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438(7070):932\u2013936. doi: 10.1038\/nature04478","journal-title":"Nature"},{"issue":"7347","key":"9508_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298\u2013307. doi: 10.1038\/nature10144","journal-title":"Nature"},{"issue":"21","key":"9508_CR3","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. New Engl J Med 285(21):1182\u20131186. doi: 10.1056\/NEJM197111182852108","journal-title":"New Engl J Med"},{"issue":"6","key":"9508_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401\u2013410. doi: 10.1038\/nrc1093","journal-title":"Nat Rev Cancer"},{"issue":"6573","key":"9508_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(6573):435\u2013439. doi: 10.1038\/380435a0","journal-title":"Nature"},{"issue":"6573","key":"9508_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O\u2019Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573):439\u2013442. doi: 10.1038\/380439a0","journal-title":"Nature"},{"issue":"5","key":"9508_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling\u2014in control of vascular function. Nat Rev Mol Cell Biol 7(5):359\u2013371. doi: 10.1038\/nrm1911","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"9508_CR8","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2(12):1097\u20131105. doi: 10.1177\/1947601911423031","journal-title":"Genes Cancer"},{"issue":"12","key":"9508_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13(12):871\u2013882. doi: 10.1038\/nrc3627","journal-title":"Nat Rev Cancer"},{"issue":"6535","key":"9508_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F Shalaby","year":"1995","unstructured":"Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376(6535):62\u201366. doi: 10.1038\/376062a0","journal-title":"Nature"},{"issue":"16","key":"9508_CR11","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","volume":"95","author":"S Hiratsuka","year":"1998","unstructured":"Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95(16):9349\u20139354","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6535","key":"9508_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/376066a0","volume":"376","author":"GH Fong","year":"1995","unstructured":"Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376(6535):66\u201370. doi: 10.1038\/376066a0","journal-title":"Nature"},{"issue":"4","key":"9508_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/ATVBAHA.107.150433","volume":"28","author":"M Murakami","year":"2008","unstructured":"Murakami M, Zheng Y, Hirashima M, Suda T, Morita Y, Ooehara J, Ema H, Fong GH, Shibuya M (2008) VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler Thromb Vasc Biol 28(4):658\u2013664. doi: 10.1161\/ATVBAHA.107.150433","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"9508_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","volume":"6","author":"HX Chen","year":"2009","unstructured":"Chen HX, Cleck JN (2009) Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol 6(8):465\u2013477. doi: 10.1038\/nrclinonc.2009.94","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"9508_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2(10):795\u2013803. doi: 10.1038\/nrc909","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"9508_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25(4):581\u2013611. doi: 10.1210\/er.2003-0027","journal-title":"Endocr Rev"},{"issue":"12","key":"9508_CR17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nrc2524","volume":"8","author":"C Fischer","year":"2008","unstructured":"Fischer C, Mazzone M, Jonckx B, Carmeliet P (2008) FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8(12):942\u2013956. doi: 10.1038\/nrc2524","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"9508_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"P Carmeliet","year":"2001","unstructured":"Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, VandenDriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7(5):575\u2013583. doi: 10.1038\/87904","journal-title":"Nat Med"},{"issue":"3","key":"9508_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","volume":"131","author":"C Fischer","year":"2007","unstructured":"Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, Autiero M, Wyns S, Plaisance S, Moons L, van Rooijen N, Giacca M, Stassen JM, Dewerchin M, Collen D, Carmeliet P (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463\u2013475. doi: 10.1016\/j.cell.2007.08.038","journal-title":"Cell"},{"issue":"6","key":"9508_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.108.816454","volume":"119","author":"JE Lahteenvuo","year":"2009","unstructured":"Lahteenvuo JE, Lahteenvuo MT, Kivela A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vahakangas E, Korpisalo P, Enholm B, Carmeliet P, Alitalo K, Eriksson U, Yla- Herttuala S (2009) Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation 119(6):845\u2013856. doi: 10.1161\/CIRCULATIONAHA.108.816454","journal-title":"Circulation"},{"issue":"7290","key":"9508_CR21","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature08945","volume":"464","author":"CE Hagberg","year":"2010","unstructured":"Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, van Meeteren LA, Samen E, Lu L, Vanwildemeersch M, Klar J, Genove G, Pietras K, Stone-Elander S, Claesson-Welsh L, Yla-Herttuala S, Lindahl P, Eriksson U (2010) Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464(7290):917\u2013921. doi: 10.1038\/nature08945","journal-title":"Nature"},{"issue":"3","key":"9508_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/path.814","volume":"193","author":"SP Gunningham","year":"2001","unstructured":"Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB (2001) VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J Pathol 193(3):325\u2013332. doi: 10.1002\/path.814","journal-title":"J Pathol"},{"issue":"7","key":"9508_CR23","first-page":"3206","volume":"61","author":"SP Gunningham","year":"2001","unstructured":"Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA, Harris AL, Fox SB (2001) Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Cancer Res 61(7):3206\u20133211","journal-title":"Cancer Res"},{"issue":"2","key":"9508_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.1339","volume":"200","author":"V Hanrahan","year":"2003","unstructured":"Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 200(2):183\u2013194. doi: 10.1002\/path.1339","journal-title":"J Pathol"},{"issue":"7204","key":"9508_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature07083","volume":"454","author":"T Tammela","year":"2008","unstructured":"Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, Waltari M, Hellstrom M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Yla-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network f ormation. Nature 454(7204):656\u2013660. doi: 10.1038\/nature07083","journal-title":"Nature"},{"issue":"6","key":"9508_CR26","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/MCB.25.6.2441-2449.2005","volume":"25","author":"ME Baldwin","year":"2005","unstructured":"Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG (2005) Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 25(6):2441\u20132449. doi: 10.1128\/MCB.25.6.2441-2449.2005","journal-title":"Mol Cell Biol"},{"issue":"1","key":"9508_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5(1):74\u201380. doi: 10.1038\/ni1013","journal-title":"Nat Immunol"},{"issue":"7070","key":"9508_CR28","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nature04480","volume":"438","author":"K Alitalo","year":"2005","unstructured":"Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438(7070):946\u2013953. doi: 10.1038\/nature04480","journal-title":"Nature"},{"issue":"24","key":"9508_CR29","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.1158\/1078-0432.CCR-04-0379","volume":"10","author":"H Kurahara","year":"2004","unstructured":"Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S, Aikou T (2004) Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res 10(24):8413\u20138420. doi: 10.1158\/1078-0432.CCR-04-0379","journal-title":"Clin Cancer Res"},{"issue":"9","key":"9508_CR30","first-page":"1136","volume":"24","author":"HG Jiang","year":"2005","unstructured":"Jiang HG, Gao M, Tang WP, Li FH, Cai QZ (2005) Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma. Ai Zheng 24(9):1136\u20131139","journal-title":"Ai Zheng"},{"issue":"1","key":"9508_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/JVI.68.1.84-92.1994","volume":"68","author":"DJ Lyttle","year":"1994","unstructured":"Lyttle DJ, Fraser KM, Fleming SB, Mercer AA, Robinson AJ (1994) Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol 68(1):84\u201392","journal-title":"J Virol"},{"issue":"3\u20134","key":"9508_CR32","first-page":"311","volume":"29","author":"DM Haig","year":"1998","unstructured":"Haig DM, Mercer AA (1998) Ovine diseases. Orf Vet Res 29(3\u20134):311\u2013326","journal-title":"Orf Vet Res"},{"issue":"2\u20133","key":"9508_CR33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-1656(99)00141-8","volume":"73","author":"HJ Rziha","year":"1999","unstructured":"Rziha HJ, Henkel M, Cottone R, Meyer M, Dehio C, Buttner M (1999) Parapoxviruses: potential alternative vectors for directing the immune response in permissive and non- permissive hosts. J Biotechnol 73(2\u20133):235\u2013242","journal-title":"J Biotechnol"},{"issue":"6","key":"9508_CR34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0007-1226(91)90209-3","volume":"44","author":"ST Tan","year":"1991","unstructured":"Tan ST, Blake GB, Chambers S (1991) Recurrent orf in an immunocompromised host. Br J Plast Surg 44(6):465\u2013467","journal-title":"Br J Plast Surg"},{"issue":"2","key":"9508_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/emboj\/18.2.363","volume":"18","author":"M Meyer","year":"1999","unstructured":"Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ, Dehio C (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18(2):363\u2013374. doi: 10.1093\/emboj\/18.2.363","journal-title":"EMBO J"},{"issue":"47","key":"9508_CR36","doi-asserted-by":"crossref","first-page":"31273","DOI":"10.1074\/jbc.273.47.31273","volume":"273","author":"S Ogawa","year":"1998","unstructured":"Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y, Shibuya M (1998) A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR\/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 273(47):31273\u201331282","journal-title":"J Biol Chem"},{"issue":"6","key":"9508_CR37","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.96.6.3071","volume":"96","author":"LM Wise","year":"1999","unstructured":"Wise LM, Veikkola T, Mercer AA, Savory LJ, Fleming SB, Caesar C, Vitali A, Makinen T, Alitalo K, Stacker SA (1999) Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 96(6):3071\u20133076","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9508_CR38","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1096\/fj.08-107219","volume":"22","author":"S Cebe-Suarez","year":"2008","unstructured":"Cebe-Suarez S, Grunewald FS, Jaussi R, Li X, Claesson-Welsh L, Spillmann D, Mercer AA, Prota AE, Ballmer-Hofer K (2008) Orf virus VEGF-E NZ2 promotes paracellular NRP- 1\/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J Off Publ Fed Am Soc Exp Biol 22(8):3078\u20133086. doi: 10.1096\/fj.08-107219","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"4","key":"9508_CR39","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.bbrc.2006.04.031","volume":"345","author":"M Cudmore","year":"2006","unstructured":"Cudmore M, Ahmad S, Al-Ani B, Hewett P, Ahmed S, Ahmed A (2006) VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem Biophys Res Commun 345(4):1275\u20131282. doi: 10.1016\/j.bbrc.2006.04.031","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9508_CR40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-291X(02)03033-4","volume":"301","author":"A Kiba","year":"2003","unstructured":"Kiba A, Sagara H, Hara T, Shibuya M (2003) VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem Biophys Res Commun 301(2):371\u2013377","journal-title":"Biochem Biophys Res Commun"},{"issue":"6015","key":"9508_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan D (1985) Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature 315(6015):115\u2013122","journal-title":"Nature"},{"key":"9508_CR42","first-page":"157","volume":"182","author":"PA Labosky","year":"1994","unstructured":"Labosky PA, Barlow DP, Hogan BL (1994) Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Found Symp 182:157\u2013168 discussion 168\u2013178","journal-title":"Ciba Found Symp"},{"issue":"24","key":"9508_CR43","first-page":"7163","volume":"60","author":"A Compagni","year":"2000","unstructured":"Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G (2000) Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 60(24):7163\u20137169","journal-title":"Cancer Res"},{"issue":"2","key":"9508_CR44","first-page":"603","volume":"62","author":"G Gannon","year":"2002","unstructured":"Gannon G, Mandriota SJ, Cui L, Baetens D, Pepper MS, Christofori G (2002) Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis. Cancer Res 62(2):603\u2013608","journal-title":"Cancer Res"},{"issue":"5","key":"9508_CR45","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/S0002-9440(10)63540-7","volume":"163","author":"P Baluk","year":"2003","unstructured":"Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM (2003) Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163(5):1801\u20131815. doi: 10.1016\/S0002-9440(10)63540-7","journal-title":"Am J Pathol"},{"issue":"5415","key":"9508_CR46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.284.5415.808","volume":"284","author":"G Bergers","year":"1999","unstructured":"Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284(5415):808\u2013812","journal-title":"Science"},{"issue":"6219","key":"9508_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/339058a0","volume":"339","author":"J Folkman","year":"1989","unstructured":"Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339(6219):58\u201361. doi: 10.1038\/339058a0","journal-title":"Nature"},{"issue":"3","key":"9508_CR48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00007890-199103000-00004","volume":"51","author":"H Ohzato","year":"1991","unstructured":"Ohzato H, Gotoh M, Monden M, Dono K, Kanai T, Mori T (1991) Improvement in islet yield from a cold-preserved pancreas by pancreatic ductal collagenase distention at the time of harvesting. Transplantation 51(3):566\u2013570","journal-title":"Transplantation"},{"issue":"1","key":"9508_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1083\/jcb.200108035","volume":"156","author":"M Innocenti","year":"2002","unstructured":"Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore PP, Scita G (2002) Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol 156(1):125\u2013136. doi: 10.1083\/jcb.200108035","journal-title":"J Cell Biol"},{"issue":"1","key":"9508_CR50","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC, Lopez-Gutierrez JC, Lord DJ, Mitchel S, Powell J, Prendiville J, Vikkula M, Board I, Scientific C (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136(1):e203\u2013e214. doi: 10.1542\/peds.2014-3673","journal-title":"Pediatrics"},{"issue":"6","key":"9508_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/bies.1069","volume":"23","author":"C Betsholtz","year":"2001","unstructured":"Betsholtz C, Karlsson L, Lindahl P (2001) Developmental roles of platelet-derived growth factors. BioEssays 23(6):494\u2013507. doi: 10.1002\/bies.1069","journal-title":"BioEssays"},{"issue":"4","key":"9508_CR52","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0002-9440(10)63905-3","volume":"162","author":"P Guo","year":"2003","unstructured":"Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ, Cavenee WK, Cheng SY (2003) Platelet- derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162(4):1083\u20131093. doi: 10.1016\/S0002-9440(10)63905-3","journal-title":"Am J Pathol"},{"issue":"6","key":"9508_CR53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","volume":"72","author":"B Millauer","year":"1993","unstructured":"Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72(6):835\u2013846","journal-title":"Cell"},{"issue":"16","key":"9508_CR54","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1073\/pnas.90.16.7533","volume":"90","author":"TP Quinn","year":"1993","unstructured":"Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90(16):7533\u20137537","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6463","key":"9508_CR55","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/367576a0","volume":"367","author":"B Millauer","year":"1994","unstructured":"Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367(6463):576\u2013579. doi: 10.1038\/367576a0","journal-title":"Nature"},{"issue":"7","key":"9508_CR56","doi-asserted-by":"publisher","first-page":"a006502","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2(7):a006502. doi: 10.1101\/cshperspect.a006502","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4\u20135","key":"9508_CR57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","volume":"39","author":"DO Bates","year":"2002","unstructured":"Bates DO, Harper SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vasc Pharmacol 39(4\u20135):225\u2013237","journal-title":"Vasc Pharmacol"},{"issue":"39","key":"9508_CR58","doi-asserted-by":"publisher","first-page":"38004","DOI":"10.1074\/jbc.M301194200","volume":"278","author":"LM Wise","year":"2003","unstructured":"Wise LM, Ueda N, Dryden NH, Fleming SB, Caesar C, Roufail S, Achen MG, Stacker SA, Mercer AA (2003) Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J Biol Chem 278(39):38004\u201338014. doi: 10.1074\/jbc.M301194200","journal-title":"J Biol Chem"},{"issue":"22","key":"9508_CR59","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/MCB.22.22.7758-7768.2002","volume":"22","author":"X Shu","year":"2002","unstructured":"Shu X, Wu W, Mosteller RD, Broek D (2002) Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol Cell Biol 22(22):7758\u20137768","journal-title":"Mol Cell Biol"},{"issue":"23","key":"9508_CR60","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1158\/0008-5472.CAN-04-2523","volume":"64","author":"I Crnic","year":"2004","unstructured":"Crnic I, Strittmatter K, Cavallaro U, Kopfstein L, Jussila L, Alitalo K, Christofori G (2004) Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Res 64(23):8630\u20138638. doi: 10.1158\/0008-5472.CAN-04-2523","journal-title":"Cancer Res"},{"issue":"4","key":"9508_CR61","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20(4):672\u2013682. doi: 10.1093\/emboj\/20.4.672","journal-title":"EMBO J"},{"issue":"4","key":"9508_CR62","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2353\/ajpath.2007.060835","volume":"170","author":"L Kopfstein","year":"2007","unstructured":"Kopfstein L, Veikkola T, Djonov VG, Baeriswyl V, Schomber T, Strittmatter K, Stacker SA, Achen MG, Alitalo K, Christofori G (2007) Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol 170(4):1348\u20131361. doi: 10.2353\/ajpath.2007.060835","journal-title":"Am J Pathol"},{"issue":"12","key":"9508_CR63","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.it.2007.09.004","volume":"28","author":"M Palma De","year":"2007","unstructured":"De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE (2007) Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 28(12):519\u2013524. doi: 10.1016\/j.it.2007.09.004","journal-title":"Trends Immunol"},{"issue":"7","key":"9508_CR64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc2868","volume":"10","author":"AS Chung","year":"2010","unstructured":"Chung AS, Lee J, Ferrara N (2010) Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 10(7):505\u2013514. doi: 10.1038\/nrc2868","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"9508_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175\u2013189. doi: 10.1016\/j.cell.2005.10.036","journal-title":"Cell"},{"issue":"2","key":"9508_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263\u2013266. doi: 10.1016\/j.cell.2006.01.007","journal-title":"Cell"},{"key":"9508_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8722-7-13","volume":"7","author":"Y Ji","year":"2014","unstructured":"Ji Y, Chen S, Li K, Li L, Xu C, Xiang B (2014) Signaling pathways in the development of infantile hemangioma. J Hematol Oncol 7:13. doi: 10.1186\/1756-8722-7-13","journal-title":"J Hematol Oncol"},{"issue":"11","key":"9508_CR68","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nm.1877","volume":"14","author":"M Jinnin","year":"2008","unstructured":"Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR (2008) Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14(11):1236\u20131246. doi: 10.1038\/nm.1877","journal-title":"Nat Med"},{"issue":"3","key":"9508_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1203\/PDR.0b013e318163a243","volume":"63","author":"A Picard","year":"2008","unstructured":"Picard A, Boscolo E, Khan ZA, Bartch TC, Mulliken JB, Vazquez MP, Bischoff J (2008) IGF-2 and FLT-1\/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 63(3):263\u2013267. doi: 10.1203\/PDR.0b013e318163a243","journal-title":"Pediatr Res"},{"issue":"10","key":"9508_CR70","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/blood-2004-04-1485","volume":"104","author":"M Uutela","year":"2004","unstructured":"Uutela M, Wirzenius M, Paavonen K, Rajantie I, He Y, Karpanen T, Lohela M, Wiig H, Salven P, Pajusola K, Eriksson U, Alitalo K (2004) PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104(10):3198\u20133204. doi: 10.1182\/blood-2004-04-1485","journal-title":"Blood"},{"issue":"22","key":"9508_CR71","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.1158\/0008-5472.CAN-07-1034","volume":"67","author":"T Schomber","year":"2007","unstructured":"Schomber T, Kopfstein L, Djonov V, Albrecht I, Baeriswyl V, Strittmatter K, Christofori G (2007) Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. Cancer Res 67(22):10840\u201310848. doi: 10.1158\/0008-5472.CAN-07-1034","journal-title":"Cancer Res"},{"issue":"11","key":"9508_CR72","doi-asserted-by":"publisher","first-page":"e14109","DOI":"10.1371\/journal.pone.0014109","volume":"5","author":"I Albrecht","year":"2010","unstructured":"Albrecht I, Kopfstein L, Strittmatter K, Schomber T, Falkevall A, Hagberg CE, Lorentz P, Jeltsch M, Alitalo K, Eriksson U, Christofori G, Pietras K (2010) Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. PLoS One 5(11):e14109. doi: 10.1371\/journal.pone.0014109","journal-title":"PLoS One"},{"issue":"2","key":"9508_CR73","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2353\/ajpath.2006.051041","volume":"169","author":"M Marcellini","year":"2006","unstructured":"Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, Ruffini F, Pesce M, Cianfarani F, Zambruno G, Orlandi A, Failla CM (2006) Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 169(2):643\u2013654. doi: 10.2353\/ajpath.2006.051041","journal-title":"Am J Pathol"},{"issue":"45","key":"9508_CR74","doi-asserted-by":"crossref","first-page":"32127","DOI":"10.1074\/jbc.274.45.32127","volume":"274","author":"SA Stacker","year":"1999","unstructured":"Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T, Alitalo K, Achen MG (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274(45):32127\u201332136","journal-title":"J Biol Chem"},{"issue":"5390","key":"9508_CR75","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1126\/science.282.5390.946","volume":"282","author":"DJ Dumont","year":"1998","unstructured":"Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282(5390):946\u2013949","journal-title":"Science"},{"issue":"8","key":"9508_CR76","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92(8):3566\u20133570","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"9508_CR77","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.0.CO;2-E","volume":"86","author":"TA Partanen","year":"1999","unstructured":"Partanen TA, Alitalo K, Miettinen M (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86(11):2406\u20132412","journal-title":"Cancer"},{"issue":"2","key":"9508_CR78","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.bbrc.2004.08.237","volume":"324","author":"A Alam","year":"2004","unstructured":"Alam A, Herault JP, Barron P, Favier B, Fons P, Delesque-Touchard N, Senegas I, Laboudie P, Bonnin J, Cassan C, Savi P, Ruggeri B, Carmeliet P, Bono F, Herbert JM (2004) Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity. Biochem Biophys Res Commun 324(2):909\u2013915. doi: 10.1016\/j.bbrc.2004.08.237","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"9508_CR79","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/emboj.2010.30","volume":"29","author":"I Nilsson","year":"2010","unstructured":"Nilsson I, Bahram F, Li X, Gualandi L, Koch S, Jarvius M, Soderberg O, Anisimov A, Kholova I, Pytowski B, Baldwin M, Yla-Herttuala S, Alitalo K, Kreuger J, Claesson-Welsh L (2010) VEGF receptor 2\/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29(8):1377\u20131388. doi: 10.1038\/emboj.2010.30","journal-title":"EMBO J"},{"issue":"2","key":"9508_CR80","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1535-6108(02)00031-4","volume":"1","author":"M Inoue","year":"2002","unstructured":"Inoue M, Hager JH, Ferrara N, Gerber HP, Hanahan D (2002) VEGF-A has a critical, non redundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell 1(2):193\u2013202","journal-title":"Cancer Cell"},{"issue":"3","key":"9508_CR81","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1158\/1535-7163.MCT-04-0261","volume":"4","author":"X Jimenez","year":"2005","unstructured":"Jimenez X, Lu D, Brennan L, Persaud K, Liu M, Miao H, Witte L, Zhu Z (2005) A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3. Mol Cancer Ther 4(3):427\u2013434. doi: 10.1158\/1535-7163.MCT-04-0261","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"9508_CR82","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/dji003","volume":"97","author":"B Pytowski","year":"2005","unstructured":"Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA (2005) Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97(1):14\u201321. doi: 10.1093\/jnci\/dji003","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"9508_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/1061186X.2015.1056189","volume":"24","author":"A Orleth","year":"2016","unstructured":"Orleth A, Mamot C, Rochlitz C, Ritschard R, Alitalo K, Christofori G, Wicki A (2016) Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy. J Drug Target 24(1):80\u201389. doi: 10.3109\/1061186X.2015.1056189","journal-title":"J Drug Target"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-016-9508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-016-9508-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-016-9508-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T01:57:22Z","timestamp":1600394242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-016-9508-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9508"],"URL":"https:\/\/doi.org\/10.1007\/s10456-016-9508-7","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}